Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.)

Femme et Homme Max 99 ans
NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.) MAJ Il y a 4 ans

A multicenter, randomized, double-blind, placebo-controlled study of the hemodynamic effects of rolofylline injectable emulsion in the treatment of patients with heart failure The objectives of this study are to estimate the effects of rolofylline, alone in addition to loop diuretic therapy, on pulmonary capillary wedge pressure, as well as other hemodynamic parameters, and...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations